Recent Finacing
Recent Raise
Teewinot Life Sciences develops cannabinoid-based therapeutics and operates proprietary biocatalytic and synthetic-biology production systems for industrial-scale, pharmaceutical-grade cannabinoids such as CBGA, CBG, THCA, THC, and CBD.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor